|
Avaliação DCF da Shattuck Labs, Inc. (STTK)
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Shattuck Labs, Inc. (STTK) Bundle
Explore o potencial financeiro da Shattuck Labs, Inc. (STTK) com nossa calculadora DCF amigável! Digite suas projeções de crescimento, margens e despesas para determinar o valor intrínseco da Shattuck Labs, Inc. (STTK) e refine sua abordagem de investimento.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.9 | 9.9 | 30.0 | .7 | 1.7 | 2.1 | 2.6 | 3.3 | 4.1 | 5.2 |
| Revenue Growth, % | 0 | 0.47537 | 202.16 | -97.83 | 154.14 | 25.66 | 25.66 | 25.66 | 25.66 | 25.66 |
| EBITDA | -24.5 | -36.3 | -43.9 | -100.3 | -87.6 | -2.1 | -2.6 | -3.3 | -4.1 | -5.2 |
| EBITDA, % | -248.1 | -365.54 | -146.21 | -15376.69 | -5287.57 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .5 | .6 | 1.4 | 3.4 | 4.0 | .9 | 1.1 | 1.4 | 1.8 | 2.2 |
| Depreciation, % | 5.43 | 6.22 | 4.6 | 517.64 | 243.93 | 43.25 | 43.25 | 43.25 | 43.25 | 43.25 |
| EBIT | -25.1 | -36.9 | -45.3 | -103.6 | -91.7 | -2.1 | -2.6 | -3.3 | -4.1 | -5.2 |
| EBIT, % | -253.53 | -371.76 | -150.81 | -15894.33 | -5531.5 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 39.1 | 335.4 | 268.8 | 161.3 | 130.6 | 2.1 | 2.6 | 3.3 | 4.1 | 5.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 3.1 | 1.8 | 10.0 | 7.2 | 1.6 | 1.2 | 1.5 | 1.8 | 2.3 | 2.9 |
| Accounts Payable, % | 30.86 | 17.66 | 33.35 | 1099.69 | 95.78 | 55.53 | 55.53 | 55.53 | 55.53 | 55.53 |
| Capital Expenditure | -.5 | -.7 | -7.9 | -11.6 | -.4 | -.7 | -.9 | -1.1 | -1.3 | -1.7 |
| Capital Expenditure, % | -4.75 | -7.32 | -26.41 | -1781.29 | -24.56 | -32.61 | -32.61 | -32.61 | -32.61 | -32.61 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -25.0 | -35.8 | -44.6 | -102.2 | -91.7 | -2.1 | -2.6 | -3.2 | -4.1 | -5.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -21.8 | -37.2 | -42.9 | -113.3 | -93.6 | -2.3 | -2.0 | -2.5 | -3.2 | -4.0 |
| WACC, % | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -9.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -4 | |||||||||
| Terminal Value | -43 | |||||||||
| Present Terminal Value | -25 | |||||||||
| Enterprise Value | -34 | |||||||||
| Net Debt | -121 | |||||||||
| Equity Value | 87 | |||||||||
| Diluted Shares Outstanding, MM | 43 | |||||||||
| Equity Value Per Share | 2.04 |
What You Will Get
- Real STTK Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Explore various scenarios to assess Shattuck Labs' future performance.
- User-Friendly Design: Designed for professionals but easy for beginners to navigate.
Key Features
- Comprehensive DCF Calculator: Features in-depth unlevered and levered DCF valuation models tailored for Shattuck Labs, Inc. (STTK).
- WACC Calculator: Pre-designed Weighted Average Cost of Capital sheet with adjustable parameters for precise analysis.
- Customizable Forecast Assumptions: Easily alter growth projections, capital expenditures, and discount rates to fit your analysis.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for Shattuck Labs, Inc. (STTK).
- Interactive Dashboard and Charts: Visual representations provide a clear overview of essential valuation metrics for streamlined analysis.
How It Works
- Step 1: Download the prebuilt Excel template featuring Shattuck Labs, Inc. (STTK) data.
- Step 2: Review the pre-filled sheets to familiarize yourself with the key metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see recalculated results, including Shattuck Labs, Inc. (STTK)'s intrinsic value.
- Step 5: Make informed investment decisions or create reports based on the outputs.
Why Choose the Shattuck Labs, Inc. (STTK) Calculator?
- All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for Shattuck Labs.
- Flexible Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes Shattuck Labs’ intrinsic value and Net Present Value.
- Ready-to-Use Data: Historical and projected data provide reliable starting points for analysis.
- High-Quality Standards: Perfect for financial analysts, investors, and business consultants focused on Shattuck Labs.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and precise valuation models for analyzing Shattuck Labs, Inc. (STTK).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver clients accurate valuation insights for Shattuck Labs, Inc. (STTK).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotech firms like Shattuck Labs, Inc. (STTK) are valued in the marketplace.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations specific to Shattuck Labs, Inc. (STTK).
- Real-World Data: Shattuck Labs' historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.